Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$66.25 +0.79 (+1.21%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Operating Expenses (2010 - 2026)

Updated

Arrowhead Pharmaceuticals' Operating Expenses was $245.35 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 26.9% from $193.32 million a year earlier and up 14.1% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Operating Expenses was $895.93 million through Jun 30, 2026, up 31.6% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $731.1 million, up 20.9% from FY2024.

  • Operating Expenses has now increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
  • In earlier fiscal years, Operating Expenses was $604.63 million in FY2024 (+35.6%), $445.74 million in FY2023 (+5.7%), $421.74 million in FY2022 (+46.8%) and $287.32 million in FY2021 (+58.6%).
  • The fiscal Q3 2026 figure marks the highest quarterly Operating Expenses in data going back to fiscal Q3 2010.
  • Compared with a year earlier, Operating Expenses has increased for 13 straight quarters, with growth averaging 26.5% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was fiscal Q1 2022 (growth of 100.1%); the worst was fiscal Q2 2023 (a decline of 11.0%).
  • Per Business Quant data, ARWR's Operating Expenses in the three fiscal quarters before Q3 2026 was $215 million (Q2 2026), $223.22 million (Q1 2026) and $212.37 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 245.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 245.35 Mn
Mar 31, 2026 215.00 Mn
Dec 31, 2025 223.22 Mn
Sep 30, 2025 212.37 Mn
Jun 30, 2025 193.32 Mn
Mar 31, 2025 161.51 Mn
Dec 31, 2024 163.91 Mn
Sep 30, 2024 162.20 Mn
Jun 30, 2024 176.14 Mn
Mar 31, 2024 126.19 Mn
Dec 31, 2023 140.10 Mn
Sep 30, 2023 124.43 Mn
Jun 30, 2023 118.53 Mn
Mar 31, 2023 98.10 Mn
Dec 31, 2022 104.68 Mn
Sep 30, 2022 115.41 Mn
Jun 30, 2022 105.32 Mn
Mar 31, 2022 110.25 Mn
Dec 31, 2021 90.76 Mn
Sep 30, 2021 103.17 Mn
API Access

Arrowhead Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ARWR&period=max&api_key=YOUR_API_KEY